Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed)
National Institutes of Health
Award ceiling
—Award floor
—Posted
May 21, 2026Closes
Sep 30, 2026Location eligibility
No specific state restriction found in this listing — check the full opportunity for details.Categories: Health
Eligible applicants: Small businesses, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), City or township governments, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, State governments, Special district governments, Others (see text field entitled "Additional Information on Eligibility" for clarification), County governments, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, For profit organizations other than small businesses, Public housing authorities/Indian housing authorities, Independent school districts, Private institutions of higher education, Native American tribal organizations (other than Federally recognized tribal governments)
Description
The purpose of this notice of funding opportunity (NOFO) is to establish a Center that trains researchers in formal product development for new substance use disorder (SUD) pharmacotherapeutics and to advance the best concepts through initial experiments via technical and financial support.